Collectively, these findings suggest that SLC25A12 dysfunction compromises mitochondrial energy metabolism, redox balance, and muscle integrity, thereby providing a potential mechanistic link between altered AGC1 activity and muscle weakness characteristic of sarcopenia. The gene discussed is SLC25A12; the disease is sarcopenia.